Probing rare Von Willebrand’s Disease causing mutations in the D4 and C-domains of Von Willebrand Factor
File(s)1-s2.0-S2475037925002468-main.pdf (1.7 MB)
Published version (pre-proof)
Author(s)
Mobayen, Golzar
El-Mansi, Sammy
Chion, Alain
Nightingale, Thomas D
McKinnon, Thomas
Type
Journal Article
Abstract
Background
Von Willebrand’s Disease is characterised by an absence or reduction of plasma Von Willebrand Factor levels or reduced protein function. While the spectrum of causative Von Willebrand’s Disease (VWD) mutations is vast, there has been limited characterisation of variants occurring within the D4-C6 domains of VWF that comprise the C-terminal portion of the molecule.
Objectives
In the present study we investigated the impact of nine putative low frequency VWD causing variants on VWF function.
Methods
Variants were generated by site directed mutagenesis and expressed in HEK293(T) cells and analysed for expression, intracellular storage and multimeric profile. The ability of Arg2379Cys to form dimers was assessed using an A2-CK fragment of VWF.
Results
Arg2379Cys, Ser2497Pro and Cys2639Tyr had significantly reduced secretion from HEK293T cells, while the other mutations all failed to be secreted. While co-transfection with wtVWF appeared to rescue expression, co-transfection with a deletion A1 construct demonstrated that only the Gly2044Asp, Glu2343Val, Ser2497Pro and Cys2693Tyr variants could be rescued. All the variants failed to form appreciable pseudo-Webiel-Palade bodies in HEK293 cells and showed abnormal multimers in cell lysates. The Arg2379Cys variant could be overexpressed by only formed monomers and some dimers. Analysis with a VWF-A2CK protein demonstrated that in the homozygous state Arg2379Cys behaves likes a type 2A variant, while it is likely to be a type 1 variant in the heterozygous state.
Conclusion
This data shows that varaints within the C-terminal region of VWF can dramatically impact proper VWF expression and can different impacts on VWF depending on homo or heterozygosity.
Von Willebrand’s Disease is characterised by an absence or reduction of plasma Von Willebrand Factor levels or reduced protein function. While the spectrum of causative Von Willebrand’s Disease (VWD) mutations is vast, there has been limited characterisation of variants occurring within the D4-C6 domains of VWF that comprise the C-terminal portion of the molecule.
Objectives
In the present study we investigated the impact of nine putative low frequency VWD causing variants on VWF function.
Methods
Variants were generated by site directed mutagenesis and expressed in HEK293(T) cells and analysed for expression, intracellular storage and multimeric profile. The ability of Arg2379Cys to form dimers was assessed using an A2-CK fragment of VWF.
Results
Arg2379Cys, Ser2497Pro and Cys2639Tyr had significantly reduced secretion from HEK293T cells, while the other mutations all failed to be secreted. While co-transfection with wtVWF appeared to rescue expression, co-transfection with a deletion A1 construct demonstrated that only the Gly2044Asp, Glu2343Val, Ser2497Pro and Cys2693Tyr variants could be rescued. All the variants failed to form appreciable pseudo-Webiel-Palade bodies in HEK293 cells and showed abnormal multimers in cell lysates. The Arg2379Cys variant could be overexpressed by only formed monomers and some dimers. Analysis with a VWF-A2CK protein demonstrated that in the homozygous state Arg2379Cys behaves likes a type 2A variant, while it is likely to be a type 1 variant in the heterozygous state.
Conclusion
This data shows that varaints within the C-terminal region of VWF can dramatically impact proper VWF expression and can different impacts on VWF depending on homo or heterozygosity.
Date Issued
2025-06-06
Date Acceptance
2025-06-02
Citation
Research and Practice in Thrombosis and Haemostasis, 2025
ISSN
2475-0379
Publisher
Wiley
Journal / Book Title
Research and Practice in Thrombosis and Haemostasis
Copyright Statement
© 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.
License URL
Identifier
10.1016/j.rpth.2025.102922
Subjects
Von Willebrand Factor
Von Willebrand's disease
variant analysis
bleeding
Publication Status
Published online
Article Number
102922
Date Publish Online
2025-06-06